Anti-EGFR Affibody® Molecule FITC (ab81872)

Overview

  • Product nameAnti-EGFR Affibody® Molecule FITC
    See all EGFR affibody® molecule
  • ConjugationFITC. Ex: 493nm, Em: 528nm
  • Conjugation notesThe molecule is conjugated at the unique C-terminal cysteine using a maleimide activated fluorescein reagent. Stability: There is no decrease in performance of the fluorescein conjugated Affibody® molecule after 10 repeated freeze and thaw cycles or after storage for 1 week in room temperature.
  • SpecificityThis product binds to human EGFR. This anti-EGFR Affibody® molecule is a specific affinity ligand selected against the extracellular domain of EGFR. The FITC conjugated Anti-EGFR Affibody® molecule is excellent as a one step reagent for fluorescence studies of EGFR expression on cells as well as for flow cytometry.
  • Tested applicationsSuitable for: Flow Cyt, ICC/IFmore details
    Unsuitable for: IHC-P
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Other Immunogen Type corresponding to EGFR.

  • Positive controlA431 cells.
  • General notesThis product is a recombinant protein produced in E.coli.

Properties

  • FunctionReceptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, amphiregulin, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin.
    Isoform 2 may act as an antagonist of EGF action.
  • Tissue specificityUbiquitously expressed. Isoform 2 is also expressed in ovarian cancers.
  • Involvement in diseaseLung cancer
    Inflammatory skin and bowel disease, neonatal, 2
  • Sequence similaritiesBelongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily.
    Contains 1 protein kinase domain.
  • Post-translational
    modifications
    Phosphorylation at Ser-695 is partial and occurs only if Thr-693 is phosphorylated. Phosphorylation at Thr-678 and Thr-693 by PRKD1 inhibits EGF-induced MAPK8/JNK1 activation. Dephosphorylation by PTPRJ prevents endocytosis and stabilizes the receptor at the plasma membrane. Autophosphorylation at Tyr-1197 is stimulated by methylation at Arg-1199 and enhances interaction with PTPN6. Autophosphorylation at Tyr-1092 and/or Tyr-1110 recruits STAT3. Dephosphorylated by PTPN1 and PTPN2.
    Monoubiquitinated and polyubiquitinated upon EGF stimulation; which does not affect tyrosine kinase activity or signaling capacity but may play a role in lysosomal targeting. Polyubiquitin linkage is mainly through 'Lys-63', but linkage through 'Lys-48', 'Lys-11' and 'Lys-29' also occurs. Deubiquitination by OTUD7B prevents degradation. Ubiquitinated by RNF115 and RNF126.
    Methylated. Methylation at Arg-1199 by PRMT5 stimulates phosphorylation at Tyr-1197.
  • Cellular localizationSecreted and Cell membrane. Endoplasmic reticulum membrane. Golgi apparatus membrane. Nucleus membrane. Endosome. Endosome membrane. Nucleus. In response to EGF, translocated from the cell membrane to the nucleus via Golgi and ER. Endocytosed upon activation by ligand. Colocalized with GPER1 in the nucleus of estrogen agonist-induced cancer-associated fibroblasts (CAF).
  • Information by UniProt
  • Alternative names
    • Avian erythroblastic leukemia viral (v erb b) oncogene homolog
    • Cell growth inhibiting protein 40
    • Cell proliferation inducing protein 61
    • EGF R
    • EGFR
    • EGFR_HUMAN
    • Epidermal growth factor receptor
    • Epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog)
    • Epidermal growth factor receptor (erythroblastic leukemia viral (v erb b) oncogene homolog avian)
    • erb-b2 receptor tyrosine kinase 1
    • ERBB
    • ERBB1
    • Errp
    • HER1
    • mENA
    • NISBD2
    • Oncogen ERBB
    • PIG61
    • Proto-oncogene c-ErbB-1
    • Receptor tyrosine protein kinase ErbB 1
    • Receptor tyrosine-protein kinase ErbB-1
    • SA7
    • Species antigen 7
    • Urogastrone
    • v-erb-b Avian erythroblastic leukemia viral oncogen homolog
    • wa2
    • Wa5
    see all
  • Database links

Applications

Our Abpromise guarantee covers the use of ab81872 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Flow Cyt Use a concentration of 0.1 - 5 µg/ml.
ICC/IF Use a concentration of 1 - 5 µg/ml.
  • Application notesIs unsuitable for IHC-P.
  • Anti-EGFR Affibody® Molecule FITC images

    • Fluorescence histogram from flow cytometry analysis on EGFR expressing A431 cells. Staining with ab81872 caused an increase in fluorescence intensity as shown by a shift to the right (red line) compared to control (black line).
    • Titration diagram from cytometry analysis of EGFR expressing A431 cells. ab81872 was titrated on EGFR expressing A431 cells. The concentration was plotted against the mean fluorescence intensity (MFI).
    • A431 cells were stained with ab81872 at 2µg/ml by Immunofluorescence. The staining was localized to the membrane of the EGFR-expressing A431 cells. The nuclei were counter stained with DAPI.

    References for Anti-EGFR Affibody® Molecule FITC (ab81872)

    ab81872 has not yet been referenced specifically in any publications.

    Product Wall

    Thank you for providing that information.

    I will go ahead and upload the information that you provided. It may take a week or so for it to appear on the webpages.

    Once again, thank you for providing that information and for your pat...

    Read More

    Thank you for your call today, and I'm sorry for the trouble with submitting your review.

    Please go ahead and send the protocol information and any data that you have on Ab81872, and I will upload the review manually, as we currently don't ha...

    Read More

    Thank you for your call today, and I'm sorry for the trouble with submitting your review.

    As we discussed, please go ahead and send the protocol information and any data that you have on Ab81872, and I will upload the review manually, as we c...

    Read More

    DISCOUNT CODE: *******Expiration date: ****** I am very pleased to hear you would like to accept our offer and test ab81872 inmouse tissue. This code will give you 1 free PRIMARY ANTIBODY before the expiration date. To redeem this offer, please submit ...

    Read More

    Thank you very much for your interest in ab81872. To our knowledge, ab81872 has not been tested in mouse tissue. Therefore, I can offer a discount off a future purchase if you buy ab81872 now, test it in mouse tissue and submit feedback to us in the fo...

    Read More

    Thanks for your inquiry. ab81872 does neutralize or block ligand binding. See PubMed reference below:Nucl Med Biol. 2007 Aug;34(6):609-18. From the abstract of that paper: "The cellular binding and processing of an epidermal growth factor...

    Read More

    Thank you for contacting us. Please be advised that ab81872 is not a conjugated antibody it is in fact an Affibody molecules. These are a novel class of antibody mimetics with superior characteristics surpassing monoclonal antibodies (mAbs) and ant...

    Read More

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"